![]() |
市场调查报告书
商品编码
1753883
2025 年至 2033 年脑监测市场报告(按产品类型、程序、应用、最终用户和地区)Brain Monitoring Market Report by Product Type, Procedure, Application, End User, and Region 2025-2033 |
2024年,全球脑监测市场规模达68亿美元。展望未来,预计到2033年,该市场规模将达到111亿美元,2025-2033年期间的复合年增长率(CAGR)为5.6%。神经系统疾病发生率的上升、脑监测设备的技术进步、人们对脑健康的日益关注以及人口老化是推动市场成长的主要因素。
神经系统疾病盛行率上升
神经系统疾病盛行率的上升是影响脑监测市场成长的重要因素。随着全球人口老化,与年龄相关的神经系统疾病(例如阿兹海默症和帕金森氏症)的发病率也在上升。例如,根据美国国家医学图书馆发表的一篇文章,人口老化显着增加了各种神经系统疾病的社会负担,包括阿兹海默症、原发性恶性脑瘤、帕金森氏症和肌萎缩侧索硬化症。此外,根据世界卫生组织 (WHO) 的数据,近 14% 的 60 岁及以上成年人患有精神疾病。此外,随着神经系统疾病变得越来越普遍,对用于准确检测和监测这些疾病的先进诊断工具的需求也日益增长。脑部监测技术,例如脑电图 (EEG)、磁振造影 (MRI) 和正子断层扫描 (PET) 扫描,在神经系统疾病的诊断和评估中发挥着至关重要的作用。例如,2024年4月,非侵入性脑刺激和协同监测技术供应商Soterix Medical Inc.推出了MxN-GO EEG,这是一款高清经颅电刺激(HD-tES)和脑电图系统,具有独特的无线设计。该技术专为需要在移动和自然环境中进行电刺激和监测脑活动的研究应用而设计。这些因素进一步促进了市场的成长。
脑电图(EEG)的应用日益广泛
脑电图 (EEG) 的应用日益广泛,大大推动了脑监测市场的成长。 EEG 对于诊断各种神经系统疾病(例如癫痫、睡眠障碍和脑肿瘤)至关重要。它能够检测脑内异常电活动,有助于准确诊断、指导治疗决策并改善患者预后。例如,2022 年 7 月,美国国立卫生研究院 (NIH) 对美国医院进行了一项调查,发现使用 EEG 设备显着提高了医生对脑电图癫痫的诊断能力。与临床诊断相比,EEG 癫痫诊断的敏感度从 77.8% 提高到 100%,特异性从 63.9% 提高到 89%。 EEG 技术的不断进步,例如高密度 EEG、便携式设备和改进的讯号处理技术,增强了其诊断能力和可用性。例如,2024年4月,NeuroVigil在美国推出了iBrain个人脑监测器,这是一款处于研究阶段的便携式设备,可以非侵入式地记录神经系统疾病患者的脑电活动。 iBrain基于脑电图(EEG)技术,该技术常用于评估脑电活动和检测神经系统异常。患者可以在家中和睡眠期间使用该设备,更有效率、更轻鬆地取得脑电图资料。这些技术改进使脑电图在各种医疗环境中更易于获取且更可靠,促进了脑电图的广泛应用和市场扩张。这些因素进一步提升了脑监测市场的占有率。
新兴神经科学研究
日益增长的神经科学研究正在促进大脑监测市场的成长。神经科学研究不断突破脑部造影技术的界限,例如MRI(磁振造影)、PET(正子断层扫描)、CT(电脑断层扫描)和EEG(脑电图)。例如,通用电气医疗集团(GE HealthCare)于2024年5月推出了SIGNA MAGNUS,这是一款尖端的头部磁振造影(MRI)扫描仪。 SIGNA MAGNUS是一项重大进步,它为科学家提供了强大的工具来深入研究大脑的复杂性。这些技术对于可视化和理解健康个体和神经系统疾病患者的大脑结构、功能和连结至关重要。此外,神经科学研究也越来越多地利用人工智慧和机器学习演算法来分析大规模脑部造影和脑电图资料。这些先进的分析工具增强了对复杂大脑活动模式的解读,识别细微的生物标记物,并预测疾病进展。此外,各种组织正在推动人工智慧在脑部疾病中的应用,以提供更好的诊断。例如,2024年2月,独立非营利组织「万脑计画」(10,000 Brains Project)成立,旨在推动人工智慧(AI)在对抗阿兹海默症、帕金森氏症和其他神经系统疾病方面的伦理应用。该组织的目标是提供所需的领导力、经验和资金支持,确保研究人员能够迅速采用这项强大的新技术,为有需要的患者提供更好的诊断和治疗。这些因素进一步推高了市场需求。
The global brain monitoring market size reached USD 6.8 Billion in 2024. Looking forward, the market is expected to reach USD 11.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.6% during 2025-2033. Growing incidences of neurological disorders, technological advancements in brain monitoring devices, surging focus on brain health, and aging population are primarily driving the market growth.
Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is a significant factor influencing the growth of the brain monitoring market. As populations around the world age, the incidence of age-related neurological disorders such as Alzheimer's disease and Parkinson's disease increases. For instance, according to an article published by the National Library of Medicine, the aging population has significantly increased the societal burden of various neurologic illnesses, including Alzheimer's disease, primary malignant brain tumors, Parkinson's disease, and amyotrophic lateral sclerosis. Moreover, according to the World Health Organization (WHO), nearly 14% of adults aged 60 and above live with a mental disorder. Apart from this, as neurological disorders become more prevalent, there is a growing need for advanced diagnostic tools to accurately detect and monitor these conditions. Brain monitoring technologies such as EEG (electroencephalography), MRI (magnetic resonance imaging), and PET (positron emission tomography) scans play a crucial role in the diagnosis and assessment of neurological disorders. For instance, in April 2024, Soterix Medical Inc., a non-invasive brain stimulation and synergistic monitoring technologies provider, launched MxN-GO EEG, a high-definition transcranial Electrical Stimulation (HD-tES) and EEG system with a unique untethered design. The technology is designed for research applications that need electrical stimulation and monitoring of brain activity in mobile and natural settings. These factors are further proliferating the market growth.
Increasing Application of Electroencephalography (EEG)
The increasing application of Electroencephalography (EEG) is significantly driving the growth in the brain monitoring market. EEG is essential for diagnosing various neurological disorders such as epilepsy, sleep disorders, and brain tumors. Its ability to detect abnormal electrical activity in the brain helps in accurate diagnosis, guiding treatment decisions and improving patient outcomes. For instance, in July 2022, the National Institute of Health performed a survey of hospitals in the United States and discovered that using EEG equipment dramatically improved electrographic seizure diagnosis by physicians. The sensitivity of electrographic seizure diagnosis increased from 77.8% to 100%, while the specificity increased from 63.9% to 89% when compared to clinical diagnosis. Continuous advancements in EEG technology, such as high-density EEG, portable devices, and improved signal processing techniques, enhance its diagnostic capabilities and usability. For instance, in April 2024, NeuroVigil introduced the iBrain personal brain monitor in the United States, which is an investigational portable gadget that can non-invasively record electrical activity in persons with neurological problems. iBrain is based on electroencephalogram (EEG) technology, which is routinely used to assess brain electrical activity and detect neurological abnormalities. Patients can use the gadget at home and during sleep to acquire EEG data more efficiently and easily. These technological improvements make EEG more accessible and reliable across diverse healthcare settings, fostering broader adoption and market expansion. These factors are further contributing to the brain monitoring market share.
Emerging Neuroscience Research
Increasing neuroscience research is contributing to the growth of the brain monitoring market. Research in neuroscience continually pushes the boundaries of brain imaging technologies such as MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), CT (Computed Tomography), and EEG (Electroencephalography). For instance, in May 2024, GE HealthCare unveiled SIGNA MAGNUS, a cutting-edge head-only magnetic resonance imaging (MRI) scanner. SIGNA MAGNUS is a major advancement that gives scientists a strong instrument to examine the intricacies of the brain in depth. These technologies are crucial for visualizing and understanding brain structure, function, and connectivity in both healthy individuals and those with neurological disorders. Besides this, neuroscience research increasingly leverages AI and machine learning algorithms to analyze large-scale brain imaging and EEG data. These advanced analytical tools enhance the interpretation of complex brain activity patterns, identify subtle biomarkers, and predict disease progression. Also, various organizations are promoting applications of artificial intelligence in brain illnesses in order to provide better diagnostics. For instance, in February 2024, the 10,000 Brains Project, an independent non-profit organization, was launched to promote the ethical application of artificial intelligence (AI) in the battle against Alzheimer's, Parkinson's, and other neurological illnesses. The organization's aim is to provide the leadership, experience, and financial assistance required to ensure that researchers can quickly adopt this powerful new technology in the pursuit of better diagnostics and treatments for patients in need. These factors are further escalating the market demand.
The demand for electroencephalography (EEG) devices is driven by the surging prevalence of epilepsy and sleep disorders. Moreover, magnetoencephalography (MEG) devices are essential for pre-surgical localization of epileptic foci and brain tumor mapping. Apart from this, the increasing incidence of stroke requiring monitoring of cerebral blood flow is bolstering the demand for transcranial doppler devices. Besides this, the demand for intracranial pressure monitors is driven by the rising cases of traumatic brain injury.
High demand in intensive care units (ICUs) for monitoring patients with traumatic brain injury, intracranial hemorrhage, and hydrocephalus is driving the demand for invasive procedures. This procedure is essential for optimizing management during neurosurgical procedures such as tumor resection or placement of shunts. Non-invasive procedures are widely used for diagnosing epilepsy and sleep disorders, and monitoring brain function in stroke, coma, and neurodegenerative diseases. Moreover, it is also utilized in neuroscience research due to accessibility and real-time monitoring capabilities.
According to the brain monitoring market overview, the demand for brain monitoring technologies in the context of specific neurological conditions such as Parkinson's disease, traumatic brain injury (TBI), epilepsy, dementia, and sleep disorders is driven by various clinical needs, advancements in technology, and research initiatives. In Parkinson's disease, there is a high demand for invasive brain monitoring techniques like intraoperative microelectrode recording (MER) and intraoperative macrostimulation (IOM). Moreover, in traumatic brain injury, intracranial pressure (ICP) monitoring is essential to manage elevated ICP levels, which can lead to secondary brain injury post-TBI, guiding treatment strategies, and improving patient outcomes.
According to the brain monitoring market analysis, hospitals use brain monitoring technologies such as CT scans and MRI to quickly diagnose and assess stroke patients. These imaging modalities help determine the type of stroke (ischemic or hemorrhagic) and guide immediate treatment decisions. While neurodiagnostic centers utilize a range of brain monitoring technologies to conduct comprehensive evaluations for patients with complex neurological symptoms. This includes EEG for seizure monitoring, MEG for functional brain mapping, and PET scans for assessing metabolic activity in the brain.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
High adoption of advanced neuroimaging in United States and Canada, technologies such as MRI, CT, and PET scans in hospitals and diagnostic centers are driving the growth in North America region. Moreover, the growth in Europe is driven by a strong focus on neuroscience research, utilizing functional imaging and EEG for understanding brain function and disorders. Apart from this, the rapidly expanding healthcare infrastructure in Asia Pacific with the increasing availability of MRI and CT scans is driving the market growth in the region.